REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $989,391 | +188.8% | 10,882 | +20.7% | 0.06% | +160.9% |
| Q4 2022 | $342,556 | +57.1% | 9,017 | +3.8% | 0.02% | +64.3% |
| Q3 2022 | $218,000 | -26.8% | 8,686 | -11.5% | 0.01% | -12.5% |
| Q2 2022 | $298,000 | -44.3% | 9,818 | -39.9% | 0.02% | -42.9% |
| Q1 2022 | $535,000 | +38.2% | 16,328 | +497.4% | 0.03% | +33.3% |
| Q2 2021 | $387,000 | -24.4% | 2,733 | -46.8% | 0.02% | -27.6% |
| Q1 2021 | $512,000 | -5.7% | 5,137 | +16.9% | 0.03% | -25.6% |
| Q4 2020 | $543,000 | -56.9% | 4,395 | -66.0% | 0.04% | -4.9% |
| Q3 2020 | $1,259,000 | +517.2% | 12,921 | +441.5% | 0.04% | +925.0% |
| Q1 2019 | $204,000 | – | 2,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |